Guardant Health insider gifts 30K shares to charity

Rhea-AI Filing Summary

Guardant Health, Inc. (GH) reported insider transactions by Co-Chief Executive Officer and director Helmy Eltoukhy involving only indirect holdings. On August 26, 2026, entities associated with him restructured 50,000 shares of common stock, moving 25,000 shares from the Helmy A. Eltoukhy Revocable Trust to The Eltoukhy Foundation, leaving the foundation holding 60,000 shares. The same trust also made a bona fide gift of 30,000 shares to a Donor Advisory Fund at Vanguard. All transactions were reported at a price of $0.00 per share and reflect ownership changes and charitable giving rather than market purchases or sales.

Insider Trade Summary

Net Seller: 30,000 shares

Net Sell 3 txns

Insider Eltoukhy Helmy

Role Co-Chief Executive Officer

Type	Security	Shares	Price	Value
Other	Common Stock F1	25,000	$0.00	$0.00
Other	Common Stock F1	25,000	$0.00	$0.00
Gift	Common Stock F2	30,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 60,000 shares (Indirect, Shares held by The Eltoukhy Foundation); Common Stock — 1,940,934 shares (Indirect, Shares held by Helmy A. Eltoukhy Revocable Trust)

Footnotes (2)

1. F1. Reflects changes in form of ownership from Helmy A. Eltoukhy Revocable Trust to The Eltoukhy Foundation.
2. F2. Reflects a gift of shares to a Donor Advisory Fund at Vanguard.

Key Figures

Restructured shares: 50,000 shares of Common Stock Transfer from trust to foundation: 25,000 shares of Common Stock Gift to Donor Advisory Fund: 30,000 shares of Common Stock +2 more

5 metrics

Restructured shares 50,000 shares of Common Stock Total shares moved in ownership restructuring on August 26, 2026

Transfer from trust to foundation 25,000 shares of Common Stock Disposition by Helmy A. Eltoukhy Revocable Trust; acquisition by The Eltoukhy Foundation

Gift to Donor Advisory Fund 30,000 shares of Common Stock Bona fide gift from Helmy A. Eltoukhy Revocable Trust to a Donor Advisory Fund at Vanguard

Shares held by The Eltoukhy Foundation after transaction 60,000 shares of Common Stock Indirect holdings following the 25,000-share acquisition

Reported transaction price $0.00 per share All three reported transactions on August 26, 2026

Key Terms

bona fide gift, Donor Advisory Fund, Revocable Trust, indirect ownership

4 terms

bona fide gift financial

"transaction_code "G" with description "Bona fide gift""

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Donor Advisory Fund financial

"Reflects a gift of shares to a Donor Advisory Fund at Vanguard."

Revocable Trust financial

"Shares held by Helmy A. Eltoukhy Revocable Trust"

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

indirect ownership financial

"ownership_type is "indirect" and direct_or_indirect is "I""

FAQ

What insider transactions did GH report for Helmy Eltoukhy on August 26, 2026?

GH reported that entities associated with Helmy Eltoukhy restructured 50,000 shares of common stock between a revocable trust and The Eltoukhy Foundation and made a bona fide gift of 30,000 shares to a Donor Advisory Fund at Vanguard.

Did Helmy Eltoukhy buy or sell GH shares in the market in this Form 4?

No. The Form 4 reports ownership changes and gifts involving indirect holdings, all at a reported price of $0.00 per share, rather than any market purchases or sales of Guardant Health common stock.

How many GH shares does The Eltoukhy Foundation hold after these transactions?

After the reported transactions, The Eltoukhy Foundation holds 60,000 shares of Guardant Health common stock, as disclosed in the Form 4 as the total shares following the 25,000-share acquisition by the foundation.

What change occurred to GH shares held by the Helmy A. Eltoukhy Revocable Trust?

The Helmy A. Eltoukhy Revocable Trust transferred 25,000 shares of GH common stock to The Eltoukhy Foundation and separately gifted 30,000 shares to a Donor Advisory Fund at Vanguard, reflecting changes in form of ownership and charitable giving.

Were GH shares given to charity in this Form 4 filing?

Yes. A bona fide gift of 30,000 GH shares was made from the Helmy A. Eltoukhy Revocable Trust to a Donor Advisory Fund at Vanguard, as described in the footnote to the gift transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 07:47 PM Accepted by SEC EDGAR 08/27/2026 - 07:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Eltoukhy Helmy

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Co-Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2026		J		25,000(1)	D	$0	1,970,934	I	Shares held by Helmy A. Eltoukhy Revocable Trust
Common Stock	08/26/2026		J		25,000(1)	A	$0	60,000	I	Shares held by The Eltoukhy Foundation
Common Stock	08/26/2026		G		30,000(2)	D	$0	1,940,934	I	Shares held by Helmy A. Eltoukhy Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects changes in form of ownership from Helmy A. Eltoukhy Revocable Trust to The Eltoukhy Foundation.

2. Reflects a gift of shares to a Donor Advisory Fund at Vanguard.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy	08/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)